In the past few years, great strides have been made in the field of personalized medicine; targeted therapies, such as antibody-drug conjugates, are on the forefront of next generation technologies that are anticipated to revolutionize the cancer treatment landscape. These therapies are theoretically capable of overcoming the setbacks associated with cytotoxic chemotherapeutics that are known...